2 results
Approved WMOCompleted
Part 1: To assess the safety and effectiveness of subcutaneous golimumab 50 mg (SC-GLM50), administered by autoinjection once monthly during 6 months, when combined with different DMARD regimens used in daily rheumatology. Part 2: In subjects who…
Approved WMORecruiting
The aim of this research is to investigate whether it is feasible and safe to pre-operatively treat patients who will undergo a distal pancreatectomy with endoscopic BOTOX® injections and if this procedure will reduce POPFS.